Cox-2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Cox-2 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Cox-2 shRNA Plasmid (h)

Product Specs
ItemCox-2 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29279-SH
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameprostaglandin-endoperoxide synthase 2
NCBI Gene AliasesCOX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2
Quantity20 µg

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) LncRNA RMRP aggravates LPS-induced HK-2 cell injury and AKI mice kidney injury by upregulating COX2 protein via targeting ELAVL1International immunopharmacologyMarch 1, 2023Xia H, Shanshan X, Sumeng L, Fang X, Tao Z, Cheng C.

(2) COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cellsBMC molecular and cell biologyApril 12, 2022Jiangang S, Nayoung K, Hongfang W, Junda L, Li C, Xuefeng B, Mingsong L.

(3) Surfactin attenuates particulate matter-induced COX-2-dependent PGE(2) production in human gingival fibroblasts by inhibiting TLR2 and TLR4/MyD88/NADPH oxidase/ROS/PI3K/Akt/NF-κB signaling pathwayJournal of periodontal researchDecember 1, 2021Vo TTT, Wee Y, Chen YL, Cheng HC, Tuan VP, Lee IT.

(4) COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated miceCancer lettersApril 1, 2021Gonçalves RM, Delgobo M, Agnes JP, das Neves RN, Falchetti M, Casagrande T, Garcia APV, Vieira TC, Somensi N, Bruxel MA, et al.

(5) Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophyRedox biologyJanuary 1, 2021Chen H, Qian Z, Zhang S, Tang J, Fang L, Jiang F, Ge D, Chang J, Cao J, Yang L, et al.

(6) Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammationJCI insightJune 18, 2020Lee HJ, Ko JH, Kim HJ, Jeong HJ, Oh JY.

(7) Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue HomeostasisCell reportsMarch 17, 2020Ko JH, Kim HJ, Jeong HJ, Lee HJ, Oh JY.

(8) Rheumatoid arthritis synovial fibroblasts promote TREM-1 expression in monocytes via COX-2/PGE(2) pathwayArthritis research & therapyJuly 8, 2019Peng A, Lu X, Huang J, He M, Xu J, Huang H, Chen Q.

(9) Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent mannerAmerican journal of translational researchJanuary 1, 2019Xu J, Yu Y, He X, Niu N, Li X, Zhang R, Hu J, Ma J, Yu X, Sun Y, et al.

(10) LincRNA Cox-2 Regulates Lipopolysaccharide-Induced Inflammatory Response of Human Peritoneal Mesothelial Cells via Modulating miR-21/NF-κB AxisMediators of inflammationJanuary 1, 2019Bian Y, Yang L, Zhang B, Li W, Wang S, Jiang S, Chen X, Li W, Zeng L.

(11) Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinomaOncology reportsDecember 1, 2018Li F, Sun Y, Jia J, Yang C, Tang X, Jin B, Wang K, Guo P, Ma Z, Chen Y, et al.

(12) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic CancersMolecular cancer therapeuticsDecember 1, 2018Maust JD, Frankowski-McGregor CL, Bankhead A 3rd, Simeone DM, Sebolt-Leopold JS.

(13) The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signalingBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieOctober 1, 2018Zhang J, He J, Zhang L.

(14) Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cellsBiochemical and biophysical research communicationsSeptember 18, 2018Dong BW, Zhang WB, Qi SM, Yan CY, Gao J.

(15) Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cellsCancer lettersJuly 1, 2018Zanotto-Filho A, Rajamanickam S, Loranc E, Masamsetti VP, Gorthi A, Romero JC, Tonapi S, Gonçalves RM, Reddick RL, Benavides R, et al.

(16) COX-2 Forms Regulatory Loop with YAP to Promote Proliferation and Tumorigenesis of Hepatocellular Carcinoma CellsNeoplasia (New York, N.Y.)April 1, 2018Xu G, Wang Y, Li W, Cao Y, Xu J, Hu Z, Hao Y, Hu L, Sun Y.

(17) COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophagesJournal of investigative medicine : the official publication of the American Federation for Clinical ResearchMarch 1, 2017Voloshyna I, Kasselman LJ, Carsons SE, Littlefield MJ, Gomolin IH, De Leon J, Reiss AB.

(18) Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathwayOncology reportsJune 1, 2016Li T, Zhong J, Dong X, Xiu P, Wang F, Wei H, Wang X, Xu Z, Liu F, Sun X, et al.

(19) Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathwayInternational immunopharmacologyApril 1, 2016Li Z, You K, Li J, Wang Y, Xu H, Gao B, Wang J.

(20) Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasisCancer scienceFebruary 1, 2016Kim KM, Im AR, Kim SH, Hyun JW, Chae S.

Be the First to Write a Review!